跳至主要内容
临床试验/ISRCTN14615267
ISRCTN14615267已完成未知

A randomised, double-blind, cross-over, placebo controlled clinical trial to demonstrate the effectiveness of a product designed to protect against establishment of a head louse infestation.

Oystershell NV0 个研究点目标入组 70 人开始时间: 2015年4月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Potential participants attending school with no upper age limit, although they must be the youngest qualifying member of the household
  • 2. Potential participants who upon examination, are confirmed to be at risk of infestation with head lice
  • 3. Potential participants who give written informed consent, or if the participant is under 16 years of age whose parent/guardian gives written informed consent to participate in the study
  • 4. Potential participants who will be available for home visits by MEC study team members over the 13 weeks of the study

排除标准

  • 1. Potential participants with a known sensitivity to sesame, sesame oil, any of the ingredients in Elimax shampoo, Elimax lotion or the placebo shampoo preparations
  • 2. Potential participants with a secondary bacterial infection of the scalp (e.g. impetigo) or who have a long term scalp condition (e.g. psoriasis of the scalp)
  • 3. Pregnant or nursing mothers
  • 4. Potential participants who have participated in another clinical study within 1 month before entry to this study
  • 5. Potential participants who have already participated in this clinical study

研究者

相似试验